DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Anne Wojcicki’s net worth is estimated at around ... In 1999, she joined Ardley Partners as a healthcare investment analyst and worked at the company for one year. She then worked as a ...

a tech advisor and former managing partner at Deloitte, according to a release. The only other board member is 23andMe's ...

On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...

Anne Wojcicki wanted to run things—alone ... Despite having zero experience in drug development, Wojcicki wanted to partner with major pharma companies to sell access to 23andMe’s database ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and ...

Anne Wojcicki has blamed 23andMe’s struggles ... winding down its internal drug development team, and is seeking partners to continue testing the two drug candidates it brought to early-stage ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration ...

a tech advisor and former managing partner at Deloitte, according to a release. The only other board member is 23andMe's co-founder and CEO Anne Wojcicki. Fernandez, Frankola and Jensen will all ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO Anne Wojcicki. The ...